Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
Imdelltra is a first-in-class immunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) marketed by Amgen Royalty Pharma...
Imdelltra is a first-in-class immunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) marketed by Amgen Royalty Pharma...
India aligns with shift in global guidelines for influenza vaccination, urgent need to prioritise preventives Transition in accordance with WHO...
FAO, UNICEF, WFP and WHO reiterate call for immediate ceasefire and unhindered humanitarian access to curb deaths from hunger and...
TryZone IQ will provide live match insights throughout the upcoming global competition, offering millions of rugby fans a clearer understanding...
22 August 2025, Geneva –The World Health Organization (WHO) and the World Meteorological Organization (WMO) have published a new joint...
© 2018 | Fortune World Media | MEDIA & ENTERTAINMENT CO. IN | Powered by Raja's Digital
© 2018 | Fortune World Media | MEDIA & ENTERTAINMENT CO. IN | Powered by Raja's Digital